AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05084690 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Unilateral resistance training
Description: Unilateral resistance training of the elbow flexors
Study NCT05084690 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Illusionary mirror visual feedback
Description: Modified Ramachandran's mirror box
Study NCT06461923 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Insole wearing
Description: The insole-wearing group is instructed to wear the insole gait analysis device as frequently and for as long as possible during outdoor activities. Participants receive feedback during 3rd to 4th week via telephone. Following a period of 6 weeks, an evaluation of the usability and satisfaction of the insole gait analysis device will be conducted.
Study NCT05266781 — intervention group
Intervention type: PROCEDURE
Intervention: Surgical repair
Description: Patients affected by a thoracoabdominal aortic aneurysm who received an open surgical repair (aneurysmectomy and aortic reconstruction with a surgical graft
Study NCT05266781 — intervention group
Intervention type: PROCEDURE
Intervention: Endovascular repair
Description: Patients affected by a thoracoabdominal aortic aneurysm who received endovascular repair (with off-the-shelf or custom-made Fenestrated/Branched-Endovascular Aortic Repair - F/BEVAR)
Study NCT03266549 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: botulinum toxin augmented surgery
Description: unilateral recess-resect procedure, or bilateral rectus muscle recession plus intraoperative injection of 2.5 to 5 units of botulinum toxin A into the recessed muscle.
Study NCT03266549 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: conventional surgery
Description: unilateral recess-resect procedure, bilateral rectus muscle recession, or 3 horizontal rectus muscle surgery according to the type of strabismus and the presence or absence of deep amblyopia. The standard correction tables will be used as a guide for the amount of muscle recession and, or resection.
Study NCT05995145 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Active hamstring flexibility exercises with hip flexion mobilization
Description: 8 weeks x 5 times per week for 20 min. In the experimental intervention, the exercise program will be based on participant education, home-based individual exercises, and regular group meetings for check-ups by a physiotherapist according to a precise set schedule.
Study NCT04833842 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Web-based childbirth preparation program based on health belief model
Description: In the three-month study, a web-based childbirth preparation program based on the Health Belief Model will be applied to primigravida women in the control group. Before starting the training program, pre-test will be applied to pregnant women and a five-week program will be implemented. A final test will be applied at the end of the program. The birth process will be evaluated immediately after the pregnant women give birth.
Study NCT06186973 — intervention group
Intervention type: OTHER
Intervention: Monitoring with Neobeat heart rate meter
Description: At the designated time for cord clamping as per clinical indication, a 10 cm segment of the umbilical cord will be double-clamped and 5 ml of preferably arterial blood will be obtained.~In infants brought to the resuscitation table, six ECG electrodes will be placed on the skin and cardiac output will be measured with a hemodynamic monitor (PhysioFlow®) for at least 10 min, or until the end of resuscitation/stabilization.
Study NCT06186973 — intervention group
Intervention type: OTHER
Intervention: Maternal arterial blood gases
Description: Arterial blood gases will be drawn from a radial artery line and analyzed at the end of a contraction at pre-specified time points during labor.
Study NCT06186973 — intervention group
Intervention type: OTHER
Intervention: Amniotic fluid lactate
Description: Amniotic fluid will be collected (2mL) and analyzed at pre-specified time points after rupture of the membranes.
Study NCT04697511 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam
Description: Participants will receive single oral dose of midazolam on Days 1, 3 and 13 under fed conditions.
Study NCT04697511 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: M2951
Description: Participants will receive multiple oral doses (twice daily) of M2951 on Day 3 to Day 13 under fed conditions.
Study NCT05818501 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: The dysphagia cups
Description: After the training period of the one of dysphagia cups, participants will start using cup to consume water during a designated period of time every day.~Participants consuming water with Cup A will drink from a static position with their chins towards their chests, the so-called Chin-Tuck maneuver. This position leads epiglottal naturally covering the trachea and causes liquid only ﬂowing to the esophagus and thus stomach. The restoring force of the membrane ensures a constant level of liquid at the upper edge of the cup and thus enables this preferred and safe drinking position.~Cup B limits the maximum volume of water flowing out of the Cup B designated by the staff. Controlled liquid flow prevents overflowing the mouth and gulping, thus reduces the risk of choking and liquid aspiration. Participants can choose to drink the water from Cup B with a straw when necessary.
Study NCT05470699 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo PET/CT
Study NCT05470699 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fluorine F 18 Piflufolastat
Description: Given IV
Study NCT05470699 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET/CT
Study NCT04276480 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Piperacillin-tazobactam
Description: At the time of ventilator-associated pneumonia diagnosis, patients will receive an initial 4g loading dose of piperacillin-tazobactam with a continuous maintenance dose of 16g per day the first day of treatment. The dose of the piperacillin-tazobactam administered the following days will be adjusted to the renal function.~The antimicrobial treatment will be adjusted to the narrower-spectrum agent after the antimicrobial susceptibility determination for a total length of treatment of seven days.
Study NCT05002790 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Data collection group
Description: Magnetic resonance imaging (MRI) allows measurement of the axes described to suggest which head and neck position would provide best anatomical alignment to reduce anterior impingement.~All the MRI scans will be conducted using 3.0 Tesla (Optima 750w, GE Medical, Milwaukee, WI, USA) using the cervical spine section of the coil. T2-weighted images in the sagittal plane will be acquired using a fast recovery fast spin echo (FRFSE) technique. The scans will take around two and half minutes and a member of the anaesthetic investigator team will be present to facilitate positional changes and maintain consistency. MRI scanning will be performed in following 3 head and neck positions:~Neutral position, Sniffing position and the Extension position.
Study NCT04132232 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: knowledge of expired maternal carbon monoxide and fetal carboxyhemoglobin levels
Description: Will use the Smokerlyzer® device at each visit and be provided information on exhaled carbon monoxide and fetal carboxyhemoglobin. Risks of adverse perinatal outcomes related to maternal carbon monoxide and fetal carboxyhemoglobin level will be provided.
Study NCT04804332 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Operative hysteroscopy
Description: Operative hysteroscopy is performed without or under local, regional or general anesthesia according to the local protocol preferably within 2 to 3 weeks after randomization. In case of highly vascularized RPOC, a repeat sonogram is performed 2 to 4 weeks after randomization to check for persistence of vascularity and to optimize operative timing. Operative hysteroscopy is then performed within 2 to 3 weeks after the repeat sonogram. Removal of the RPOC is performed by an experienced gynecologist using hysteroscopic morcellation (TruClearTM Hysteroscopic Tissue Removal System (Medtronic, Minneapolis, MN, USA)) and according to the local protocol.
Study NCT04804332 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Expectant management
Description: No treatment will be offered. Patients will be given telephone numbers to contact a doctor. In case of severe complaints, defined as heavy uterine bleeding and/or severe abdominal pain, not responding to conservative treatment, an emergency curettage or operative hysteroscopy may be performed.
Study NCT06286566 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Implant placement with soi surface in diabetic subjects
Description: Implants placement with SOI surface in subjects with diabetes who have lost at least one tooth element and need of a prosthetic implant-supported rehabilitation. After osseointegration implants will receive definitive prosthesis.
Study NCT06286566 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Implant placement with soi surface in healthy subjects
Description: Implants placement with SOI surface in subjects without diabetes who have lost at least one tooth element and need of a prosthetic implant-supported rehabilitation. After osseointegration implants will receive definitive prosthesis.
Study NCT05439720 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Ketone ester
Description: A dose of 25g of ketone ester after each training session and 30 minutes before sleeptime. The total dose is 75g of ketone ester.
Study NCT05439720 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Collagen peptan (3g) mixed with 1 mM bitter sucrose octaacetate and 20ml of pure water. A dose of 25g of placebo drink is provided after each training session and 30 minutes before sleeptime. The total dose is 75g of placebo drink.
Study NCT05439720 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: A 120 minutes cycling endurance training session (ET) two hours after breakfast and an evening high-intensity-interval training (HIIT) ending one hour before bedtime
Study NCT05439720 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Exercise
Description: A 120 minutes cycling endurance training session (ET) two hours after breakfast and an evening high-intensity-interval training (HIIT) ending one hour before bedtime
Study NCT04881526 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: D-beta-hydroxybutyrate
Description: Drink containing D-beta-hydroxybutyrate administered at a dose of 395 mg/kg.
Study NCT04881526 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Isocaloric flavored water with medium-chain triglyceride oil.
Study NCT05539183 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Blood withdrawal
Description: Blood withdrawal
Study NCT05228119 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Oncolytic Virus Injection(RT-01)
Description: Intravenous injection with or without intratumoral injection of a single dose of RT-01 and intravenous infusion of Nivolumab
Study NCT06716645 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Robitussin Maximum Strength Cough and Chest Congestion DM
Description: Dextromethorphan Hydrobromide, United States Pharmacopeia (USP) 20 milligram (mg) and Guaifenesin, USP 400 mg
Study NCT06716645 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Robitussin Maximum Strength Cough and Chest Congestion DM
Description: Dextromethorphan Hydrobromide, USP 20 mg and Guaifenesin, USP 400 mg
Study NCT06716645 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Robitussin Maximum Strength Nighttime Cough DM
Description: Dextromethorphan Hydrobromide, USP 30 mg and Doxylamine Succinate, USP 12.5 mg
Study NCT06724640 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VH4011499 Injection
Description: VH4011499 Injection will be administered either subcutaneously or intramuscularly.
Study NCT06724640 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo for VH4011499 Injection
Description: Placebo for VH4011499 Injection will be administered either subcutaneously or intramuscularly.
Study NCT06722586 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sirolimus
Description: Sirolimus two pills (1mg) per day
Study NCT06722586 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo two pills per day
Study NCT06733428 — intervention group
Intervention type: DEVICE
Intervention: Pachymeter
Description: Measure the thickness of the cornea
Study NCT06746688 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ES2B-C001
Description: Vaccine; Administration with or without Montanide™ every third week for a total of five vaccinations.
Study NCT06746688 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ISA 51 VD
Description: Adjuvant; Administration together with ES2B-C001 every third week for a total of five vaccinations.
Study NCT06769100 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Ketone Monoester (KET)
Description: - Ketone monoester supplement (R)-3-hydroxybutyl (R)-3-hydroxybutyrate based on participants' body weight (0.36g/kg body weight). The ketone brand name: delta G Oxford Ketone Ester
Study NCT06769100 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Ketone Monoester + Whey Protein (KET+PRO)
Description: * Ketone monoester supplement (R)-3-hydroxybutyl (R)-3-hydroxybutyrate based on participants' body weight (0.36g/kg body weight)~* 25g Whey Protein~* L-\[ring-2H5\]-phenylalanine tracer (enriched to 4%)
Study NCT06769100 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Whey Protein (PRO)
Description: * 25g Whey Protein~* L-\[ring-2H5\]-phenylalanine tracer (enriched to 4%)
Study NCT06769100 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Flavour matched placebo (CON)
Description: - Flavoured water (non-caloric bitter + citrus flavours)
Study NCT06769100 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Resistance exercise
Description: - 8 sets of 10 reps at 90% of 10- repetition maximum (10-RM) of unilateral leg extension with 90 seconds rest in between sets.
Study NCT06430151 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CUE1
Description: Sternal worn focused vibrotactile stimulation and cueing device
Study NCT05571761 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive stimulation program
Description: The cognitive stimulation program consists of 12 sessions of approximately 45 minutes, distributed in a first stage of training and psychoeducation (1 session), a second stage to address emotional aspects of anxiety and depression (2 sessions), and neuropsychological training (8 sessions) and a final closing stage with one session. There will be two sessions per week for 6 weeks.~The neuropsychological training includes 20 activities whose level of difficulty will vary according to the number of stimuli and the time of stimuli presentation. It includes 5 attentional activities, 3 memory activities, 5 executive functioning activities, one visuospatial skills activity and 6 ecological activities. These activities will be developed on a digital computer platform where patients will be assigned an identification and password to ensure confidentiality.
Study NCT05571761 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Cognitive stimulation program
Description: The cognitive stimulation program consists of 12 sessions of approximately 45 minutes, distributed in a first stage of training and psychoeducation (1 session), a second stage to address emotional aspects of anxiety and depression (2 sessions), and neuropsychological training (8 sessions) and a final closing stage with one session. There will be two sessions per week for 6 weeks.~The neuropsychological training includes 20 activities whose level of difficulty will vary according to the number of stimuli and the time of stimuli presentation. It includes 5 attentional activities, 3 memory activities, 5 executive functioning activities, one visuospatial skills activity and 6 ecological activities. These activities will be developed on a digital computer platform where patients will be assigned an identification and password to ensure confidentiality.
Study NCT05909306 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Education Group
Description: Two online meetings were planned with the education group. In the first meeting, an average of 35-minute-long live lecturing was performed on filling out the data forms and using the partograph e-learning tool through e-learning tool created in the first interview. The researcher held the second interview one week after the first one. In the second interview, a live lecture lasting 30 minutes was given to talk about and solve the problems that students experienced with the partograph e-learning tool and answer the questions. The partograph e-learning tool was kept open for one month for the students in the education group. At the end of the one-month education, the students were asked to fill out the post-test (Academic Achievement Test) defined in the system. After the post-test was completed, the system was closed to the access of the students in the education group and made available to the students in the control group.
Study NCT06769100 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Resistance exercise
Description: - 8 sets of 10 reps at 90% of 10- repetition maximum (10-RM) of unilateral leg extension with 90 seconds rest in between sets.
Study NCT06772779 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Warfarin
Description: single oral dose
Study NCT06772779 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Enlicitide Decanoate
Description: single oral dose
Study NCT06772779 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lisinopril
Description: single oral dose
Study NCT06773221 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chiglitazar 64mg
Description: Chiglitazar 64mg, oral, qd, for 72 weeks
Study NCT06773221 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo, oral, qd, for 72 weeks
Study NCT06772844 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: fecal DNA methylation testing
Description: Three rounds of screening were performed. In the first year, colonoscopy was conducted along with concurrent fecal DNA testing performed prior to the colonoscopy. In the second year, fecal DNA testing was performed only if no polyps were detected during the colonoscopy in the first year; otherwise, both colonoscopy and fecal DNA testing were conducted. In the third year, a colonoscopy was performed with concurrent fecal DNA testing conducted before the procedure
Study NCT06772168 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CMG190303(Dapagliflozin/Rosuvastatin)
Description: 0-8 week: Dapagliflozin 10mg and Rosuvastatin 5mg 8-16 week: Dapagliflozin 10mg and Rosuvastatin 10mg 16-24 week: Dapagliflozin 10mg and Rosuvastatin 20mg
Study NCT06772168 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Comparator 1: Dapagliflozin/Rosuvastatin placebo
Description: 0-24 week: Dapagliflozin 10mg and Rosuvastatin placebo
Study NCT06772168 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Rosuvastatin/Dapagliflozin placebo
Description: 0-8 week: Dapagliflozin placebo and Rosuvastatin 5mg 8-16 week: Dapagliflozin placebo and Rosuvastatin 10mg 16-24 week: Dapagliflozin placebo and Rosuvastatin 20mg
Study NCT06770075 — intervention group
Intervention type: OTHER
Intervention: Observational
Description: Participants will not receive any study intervention. During the six month study period, participants will complete four active assessments at Months 0, 1, 3 and 6, and data from the study-provided wearable (Fitbit Charge 6) and sensors from the participant's smartphone (through the Brightline app) will be collected passively throughout.
Study NCT06775288 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hypoglycemia prevention and awareness program (HypoPAP)
Description: Online hypoglycemia prevention and awareness training Supporting the prevention of hypoglycemia with the use of evidence-based diabetes-friendly plates Encouraging physical activity and supporting glycemic control with a pedometer Filling in a weekly problem-solving notebook Conducting weekly online problem-solving meetings Online counseling service when needed
Study NCT06776393 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: ultrasound
Description: Dynamic translaryngeal Ultrasound Motion mode ultrasound of the laryngeal region during phonation Acoustic recordings VHI questionnaires
Study NCT06775405 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AK0529
Description: Active Substance: AK0529, Pharmaceutical Form: Enteric pellets, Route of Administration: Oral
Study NCT06775405 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Active Substance: Placebo, Pharmaceutical Form: Enteric pellets, Route of Administration: Oral
Study NCT06776991 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Positive Affect Treatment - Behavioral (PAT-B)
Description: 8 therapy sessions conducted individually with a therapist. Focuses on improving reward processing to increase positive emotional experience. Specific techniques include psychoeducation on mood cycle and positive emotions, mood monitoring, behavioral activation, and imaginal recounting and savoring of behavioral activation events. Intervention includes between-session practice.
Study NCT06776991 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Relaxation Treatment
Description: 8 therapy sessions conducted individually with a therapist. Focuses on mindfulness and relaxation skills. Specific techniques include mindfulness approaches from dialectical behavior therapy, diaphragmatic breathing, and progressive muscle relaxation. Intervention includes between-session practice.